MyFinsight
Home
Blog
About
Investments
$3,415M
(-11.34%↓ Y/Y)
Cash and cash
equivalents
$1,723M
(34.71%↑ Y/Y)
Prepaid expenses and
other current assets
$380M
(-50.26%↓ Y/Y)
Inventory
$280M
(16.67%↑ Y/Y)
Accounts receivable, net
$17M
(-52.78%↓ Y/Y)
Total current assets
$5,815M
(-5.77%↓ Y/Y)
Property, plant and
equipment, net
$2,059M
(-5.07%↓ Y/Y)
Investments, non-current
$1,772M
(-25.36%↓ Y/Y)
Right-of-use assets,
operating leases
$697M
(-7.07%↓ Y/Y)
Other non-current
assets
$618M
(13.19%↑ Y/Y)
Total assets
$10,961M
(-8.73%↓ Y/Y)
Total liabilities and
stockholders equity
$10,961M
(-8.73%↓ Y/Y)
Total stockholders
equity
$6,761M
(-28.07%↓ Y/Y)
Total liabilities
$4,200M
(60.86%↑ Y/Y)
Retained earnings
$5,098M
(-38.20%↓ Y/Y)
Additional paid-in capital
$1,644M
(45.87%↑ Y/Y)
Accumulated other
comprehensive income
$19M
(-17.39%↓ Y/Y)
Total current
liabilities
$2,534M
(61.20%↑ Y/Y)
Operating lease
liabilities, non-current
$638M
(-4.20%↓ Y/Y)
Long-term debt
$591M
Other non-current
liabilities
$284M
(2.90%↑ Y/Y)
Deferred revenue,
non-current
$147M
(126.15%↑ Y/Y)
Financing lease
liabilities, non-current
$6M
(-81.25%↓ Y/Y)
Accrued liabilities
$1,909M
(93.41%↑ Y/Y)
Deferred revenue
$295M
(35.32%↑ Y/Y)
Accounts payable
$167M
(-4.57%↓ Y/Y)
Other current
liabilities
$163M
(-15.10%↓ Y/Y)
Back
Back
Balance Sheet
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
source: myfinsight.com
Moderna, Inc. (MRNA)